Literature DB >> 8219491

Monoclonal antibodies with in vitro borreliacidal activities define the outer surface proteins A and B of Borrelia burgdorferi.

M Moskophidis1, B Luther.   

Abstract

Thirteen monoclonal antibodies (mAb) were produced against Borrelia burgdorferi strains B31 and PKa. Five mAb recognized the outer surface protein OspA (relative molecular mass (M(r)) 31,000) and four OspB with an M(r) of 34,000. Two of these mAb were directed against flagellin with an M(r) of 41,000, and the remaining two against the antigens of B. burgdorferi with M(r) values of 19,000 and 17,000. Immunoblot and immunofluorescence studies with these mAb on five isolates of B. burgdorferi revealed differences in the individual antigenic epitopes of OspA and OspB. OspA and OspB specific mAb showed a borreliacidal activity in vitro. These antibodies were additionally reactive in haemagglutination and immunofluorescence assays. Enzymatic digestion investigations on intact borreliae suggest that the antigenic determinants of mAb with borreliacidal activity are located in the peptide chain of OspA and OspB.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8219491     DOI: 10.1016/s0934-8840(11)80398-1

Source DB:  PubMed          Journal:  Zentralbl Bakteriol        ISSN: 0934-8840


  8 in total

1.  Production of borreliacidal antibody to outer surface protein A in vitro and modulation by interleukin-4.

Authors:  E L Munson; B K Du Chateau; D A Jobe; S D Lovrich; S M Callister; R F Schell
Journal:  Infect Immun       Date:  2000-10       Impact factor: 3.441

2.  Sensitivity and specificity of the borreliacidal-antibody test during early Lyme disease: a "gold standard"?

Authors:  S M Callister; D A Jobe; R F Schell; C S Pavia; S D Lovrich
Journal:  Clin Diagn Lab Immunol       Date:  1996-07

3.  Interleukin-6 promotes anti-OspA borreliacidal antibody production in vitro.

Authors:  Erik L Munson; Dean T Nardelli; K H Kevin Luk; Monica C Remington; Steven M Callister; Ronald F Schell
Journal:  Clin Vaccine Immunol       Date:  2006-01

4.  Complement-mediated serum sensitivity among spirochetes that cause Lyme disease.

Authors:  A P van Dam; A Oei; R Jaspars; C Fijen; B Wilske; L Spanjaard; J Dankert
Journal:  Infect Immun       Date:  1997-04       Impact factor: 3.441

5.  Inhibition of the production of anti-OspA borreliacidal antibody with T cells from hamsters vaccinated against Borrelia burgdorferi.

Authors:  J R Jensen; B K Du Chateau; E L Munson; S M Callister; R F Schell
Journal:  Infect Immun       Date:  1998-04       Impact factor: 3.441

6.  Gamma interferon inhibits production of Anti-OspA borreliacidal antibody in vitro.

Authors:  Erik L Munson; Brian K Du Chateau; Jani R Jensen; Steven M Callister; David J DeCoster; Ronald F Schell
Journal:  Clin Diagn Lab Immunol       Date:  2002-09

7.  Neutralization of gamma interferon augments borreliacidal antibody production and severe destructive Lyme arthritis in C3H/HeJ mice.

Authors:  Erik L Munson; David J DeCoster; Dean T Nardelli; Douglas M England; Steven M Callister; Ronald F Schell
Journal:  Clin Diagn Lab Immunol       Date:  2004-01

8.  Seroprevalence of Borrelia burgdorferi in occupationally exposed persons in the Belgrade area, Serbia.

Authors:  Dragutin Jovanovic; Sonja Atanasievska; Vesna Protic-Djokic; Uros Rakic; Elvira Lukac-Radoncic; Elizabeta Ristanovic
Journal:  Braz J Microbiol       Date:  2015-07-01       Impact factor: 2.476

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.